Weight loss drugs may help fight migraines

Date:

Share this article:

Del denne artikel:

Early research suggests GLP-1 drugs may reduce migraine symptoms in some patients.

Living with migraine often means putting everyday life on hold without warning. A severe attack can disrupt work, family plans, and even simple daily activities, making the search for better treatments a priority for millions of people.

According to research presented at the American Academy of Neurology's Annual Meeting and reported by Health, scientists are investigating whether GLP-1 medications, widely used to treat type 2 diabetes and obesity, could also play a role in migraine management. While the evidence remains preliminary, the findings have attracted growing attention, reports VeryWell Health.

Fewer severe migraine episodes

An observational study involving more than 20,000 adults with migraine compared several GLP-1 medications with topiramate, a commonly prescribed preventive treatment.

People taking GLP-1 drugs were less likely to require emergency department visits or hospitalization. However, researchers emphasize that the study found an association rather than proving that the medications directly prevent migraine attacks.

Also read: Experts say this viral skincare trend may actually have real benefits

More than weight loss

Scientists are also exploring why these medications may influence migraine symptoms. Smaller studies suggest some patients experienced fewer headaches even before significant weight loss occurred.

This has led researchers to investigate whether GLP-1 drugs may reduce inflammation or lower pressure around the brain, rather than relying solely on weight loss to improve symptoms.

More research is still needed

Experts caution that GLP-1 medications are not approved for migraine prevention, and current evidence is not strong enough to recommend them for off-label use. Larger placebo-controlled clinical trials are needed to confirm both their effectiveness and long-term safety.

Even so, researchers believe GLP-1 therapies could eventually become an important addition to migraine treatment, particularly for people who also live with obesity or other metabolic conditions.

Also read: Scientists discover unexpected brain activity in life's final moments

For now, the findings represent an encouraging step toward expanding future treatment options.

Also read: Researchers discover surprising link between stepping speed and longevity

This article is made and published by Mie Hermansen, who may have used AI in the preparation.

Other articles

New sleep apnea pill cuts breathing interruptions nearly in half

If approved, it would be the first daily pill for sleep apnea, and millions who gave up on their CPAP may finally have another option.

How cottage cheese can affect your blood sugar

Cottage cheese is high in protein and low in carbohydrates, but what does that actually mean for your...

Giving your child a smartphone may raise their eating disorder risk

New research suggests the age a child gets their first phone may matter more than most parents realize.

Study of 159,000 women finds unhealthy sleep patterns are linked to 10 percent higher breast cancer risk

A late bedtime, short nights and restless sleep may add up to something more than a hard morning.

New sleep apnea pill cuts breathing interruptions nearly in half

If approved, it would be the first daily pill for sleep apnea, and millions who gave up on their CPAP may finally have another option.

How cottage cheese can affect your blood sugar

Cottage cheese is high in protein and low in carbohydrates, but what does that actually mean for your...

Giving your child a smartphone may raise their eating disorder risk

New research suggests the age a child gets their first phone may matter more than most parents realize.